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O R I G I N A L C O M M U N I C A T I O N
Although African-American men have a greater burden of
prostate cancer than whites and other racial and ethnic
groups, few studies on the burden of prostate cancer have
focused on African Americans specifically. We used a sam-
ple of African-American men (N=736) who participated in
the 2000 National Health Interview Survey to explore their
awareness of the prostate-specific antigen (PSA) test.
Among African-American men aged ≥45 with no history of
prostate cancer, 63% had heard of the PSA test and 48%
had been tested. Bivariate analyses showed significant
associations between sociodemographic, family composi-
tion, health status and perceived risk with having heard of
the PSA test and having been tested. The multivariate mod-
el showed significant associations between having heard of
the PSA test and age, level of education, living in an MSA,
and having private or military health insurance. For ever
being tested, the multivariate model showed significant
associations for age, private or military health insurance,
being in fair or poor health, and having a family history of
prostate cancer. Some of the correlates, such as age,
increased levels of education and being married, were con-
sistent with previous studies, but other correlates, such as
metropolitan statistical area, health status and perceived
risk, differed from previous studies.
Key words: prostate cancer  screening  prostate-
specific antigen
INTRODUCTION
Although deaths from prostate cancer have
declined over the past several years, prostate cancer
remains the leading cancer among men, and the sec-
ond leading cause of cancer mortality among men in
the United States.1 During 2004, an estimated
230,110 men will be diagnosed with prostate cancer,
and about 29,900 men are predicted to die from the
disease.2 African-American men have greater inci-
dence of prostate cancer and higher mortality rates
from the disease than other ethnic or racial groups in
the United States.2 Incidence among African-Ameri-
can men appears to be about 60% higher than the
rate for white men.2 Comparisons to Asian/Pacific
Islanders are even more striking, as African-Ameri-
can men have more than three times the incidence
and almost six times the death rate from prostate
cancer.1 In addition, there is some evidence that
prostate cancer may develop at earlier ages in
African Americans than in the general population.2,3
Further, African-American men have a greater like-
lihood of more advanced stage at the time of diagno-
sis.4,5 Finally, prostate cancer is more likely to occur
in men with a first-degree relative (such as a father
or brother) who has had the disease. It is not known
whether the differences described are due to biology,
behavior, environment, access to healthcare, culture
or a combination of these factors.
The literature on awareness of prostate cancer
and knowledge about the disease has been mixed
over the past several years. Some studies have
reported low levels of awareness and knowledge
among men in general,6-8 while others have reported
moderate-to-higher levels of awareness and know-
ledge.9,10 Other studies showed that African-Ameri-
can men have lower levels of knowledge regarding
prostate cancer than white men.11,12 Variables
describing demographic and socioeconomic status
variables, including years of education, level of
income and race, have been associated with aware-
ness and knowledge.11,13
White men are more likely than African Ameri-
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cans to undergo the prostate-specific antigen (PSA)
test,13,14 and being older14,15 and having higher levels
of education or income13,14 have been associated with
greater knowledge or test use.16 Variables describing
family have been linked to use of the PSA test.
Being married has been associated with both
increased knowledge and greater use of the PSA
test,15,17 and having health insurance has been linked
to using the test.18 Finally, spouses19 and family
members and friends have been found to have a role
in screening decisions and test use.20
None of the studies specific to African-American
men have examined associations of sociodemo-
graphic and related variables with either knowledge
of prostate cancer or test use.8 Furthermore, none of
these studies examined other types of variables, such
as health status, family history and perceived risk of
getting cancer among African-American men. 
Using the National Health Interview Survey
(NHIS) 2000, the present study examines know-
ledge about the PSA test and use of the test among
non-Hispanic African-American men aged ≥45 by
sociodemographic, family composition, health sta-
tus and perceived risk variables. The major purposes
of the study were to examine the prevalence of being
aware of the PSA test and using that test and exam-
ining factors that may be related to both awareness
and test use among African-American men. 
Method
The NHIS 2000 is a nationally representative
health survey conducted by the National Center for
Table 1. Characteristics of Non-Hispanic Black Men Aged 45 or Older, NHIS 2000 Survey
Sociodemographics N %a
Age (Years) 736
45 to 49 29.5
50 to 64 45.2
65+ 25.3
Education 723
< High-school graduate 34.6
High-school graduate 30.9
Some college/tech school 20.9
College grad 13.6
Poverty Threshold 736
<200% 28.9
200-299% 13.7
300-399% 9.1
400-599% 7.5
500%+ 14.6
Unknown 26.2
Region 736
Northeast 16.6
Midwest 16.8
South 58.8
West 7.8
Metropolitan Statistical Area 736
No 13.9
Yes 86.1
Perceived Risk N %a
Perceived Risk of Getting Cancer 599
Low 69.6
Medium 22.5
High 8.0
Perceived Amount of Cancer in Family 657
Low 80.5
Medium 14.8
High 4.7
Health Status N %a
Health Insurance 730
None 13.4
Public 23.1
Private/military 63.5
Health Status 731
Excellent 18.7
Very good 20.5
Good 32.1
Fair or poor 28.7
Family History of Prostate Cancer 686
Yes 6.2
No 93.8
Had Colorectal Screeningb 505
Yes 30.8
No 69.2
Family Composition N %a
Marital Status 733
Married/living with partner 63.0
Widowed 7.3
Divorced or separated 18.0
Never married 11.7
Family Size (Persons in the Family) 736
1 27.6
2 34.8
3+ 37.5
Family Structure 736
One adult, no children 27.6
Multiple adults, no children 47.9
One adult, 1+ children 1.1
Multiple adults, 1+ children 23.3
a Adjusted to the US 2000 Census; b Question asked of men ≥50
years of age.
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Health Statistics.21 NHIS data are collected through
personal household interviews. The NHIS 2000 used
a complex sample design involving stratification,
clustering and multistage sampling. The NHIS 2000
survey collected information related to cancer pre-
vention and control. African-American and Hispanic
populations were oversampled to allow for more
precise estimations. In the overall survey, men aged
≥40 were asked questions related to prostate cancer
screening awareness and test use. Sample weights
were constructed to reflect the total population of
the United States in 2000.21 More details of the over-
all study methods are available in the 2000 NHIS
Survey Description.21
Study Population
This sample was restricted to non-Hispanic
African-American men aged ≥45. Those men who
reported having prostate cancer were excluded.
Interviews were conducted with approximately 736
African-American male adults, with an overall adult
sample response rate of 72.1%.
Data Collection
Respondents were asked if they had heard of the
PSA test, and if so, whether they had ever had a PSA
test. We examined four sets of factors that may influ-
ence both having heard of the PSA test and ever hav-
ing had a PSA test: sociodemographic, perceived risk,
health status and family composition. Demographic
variables included age, level of education, region of
the country and metropolitan statistical area (MSA).
Regions and MSAs are defined by the Census Bureau
and Office of Management and Budget (OMB).22 The
OMB defines an MSA as one or more counties that
contain a city of 50,000 or more, or an urbanized area
that has a total population of at least 100,000. Family
income was expressed in relation to federal poverty
levels published by the U.S. Census.23 For 2000, the
poverty level for a family of four was set at $17,603.
“Unknown” family income was included as a catego-
ry due to the relatively large rate (26.2%) of nonre-
sponse for the question on income.
For family composition variables, marital status
was divided into four categories, family size into
three, and family structure into four categories (Table
1). Health-related variables included health insurance
(none, public or private), reported health status or a
self-assessment of general health (four categories),
family history of prostate cancer, and whether respon-
dents had received colorectal cancer screening.
For family history and perceived risk variables,
first-degree family history of prostate cancer was
obtained from several questions about cancer diag-
noses in respondents’ biological fathers, brothers
and sons. For perceived risk of getting cancer (in
general) and perceived amount of cancer in one’s
family, respondents were asked subjective assess-
ment questions about their likelihood of getting any
type of cancer and the amount (low, medium or
high) of any type of cancer in their families.
Data Analysis
The statistical program SUDAAN24 was used in
the analysis to take into account the complex multi-
stage probability sampling design of the NHIS 2000.
The 95% confidence interval was used to assess
variability in the estimates of percentages. General
linear contrast measures were calculated to assess
statistical significance of differences among men
within the categories of a variable—for example,
differences in test use with men from the northeast
and men from the south. P values for general linear
contrasts compare a row percent to its reference lev-
el. The Wald Chi-squared test was used to assess the
association of each variable with the outcome vari-
able after adjusting for age. The final logistic model
contained 12 main effects. Odds ratios were used to
examine the associations of independent variables
with having heard of the PSA test and having been
tested while adjusting for other variables in the mod-
el. Family structure was dropped due to its strong
association with marital status and family size.
Fifty-five of the 736 men interviewed were excluded
from the study because they did not answer the ques-
tion, “Have you ever heard of a PSA, or prostate-
specific antigen test?”
Results
Characteristics of non-Hispanic African-Ameri-
can men aged ≥45 (not suffering from prostate can-
cer) as determined from the NHIS sample are pre-
sented in Table 1. Approximately two-thirds were
high-school graduates or above, more than half were
from the south, and the majority resided in an MSA.
Over half were married and had private and/or mili-
tary insurance. Ninety-four percent had no first-
degree family history of prostate cancer, and 69%
had not been screened for colorectal cancer. Most of
these men also perceived themselves at low risk of
getting cancer in general, and most perceived the
amount of cancer in their own family to be low. 
Overall, an estimated 63% of African-American
men aged ≥45 who did not have prostate cancer had
heard of the PSA test, and 48% had had the PSA test
(Table 2). For both having heard of the PSA test
(N=681) and having had the test (N=674), significant
associations were found in each of the four categories of
variables. There were significant associations with all
sociodemographic and family composition variables,
all but one of the health status variables but none of the
perceived risk variables. Specifically, being 50–64
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years of age, having higher levels of education, higher
incomes, living in the northeast versus the midwest, and
residing in an MSA were associated with having heard
of the PSA. Also, men who were married or living with
their partners, men living in families of ≥2, men with
private or military health insurance, men with a family
history of prostate cancer, those who had been screened
for colorectal cancer, and men with a high perceived
amount of cancer in their families were more likely to
have heard of the PSA test than others. For ever having
had a PSA test (Table 2, column 2), significant associa-
tions were similar with the exception that men ≥65 were
Table 2. Percentage of Non-Hispanic Black Mene age 45 or Older
Who Had Heard of a PSA Test or Who Had Ever Had a PSA Test by Population Subgroups
Heard of PSA Test Ever Had a PSA Test
N %a CIb GLC Wald N %a CIb GLC Wald
PVc PVd PVc PVd
All 681 63.2 58.8-67.5 674 47.7 43.7-51.7
Sociodemographics
Age (Years)
45 to 49 164 54.7 45.5-63.9 ref 0.07 163 29.3 22.1-36.5 ref 0.00
50 to 64 325 67.5 61.1-73.9 0.03 320 51.3 44.9-57.6 0.00
65+ 192 64.5 57.5-71.5 0.08 191 54.7 46.7-62.7 0.00
Education
< High school graduate 242 46.3 39.8-52.7 ref 0.00 242 37.1 31.0-43.1 ref 0.00
High school graduate 195 70.5 63.1-77.9 0.00 191 52.6 45.1-60.1 0.00
Some college/tech school 148 76.7 69.5-83.9 0.00 145 59.6 49.4-69.8 0.00
College grad 88 80.9 72.9-88.9 0.00 88 49.4 38.2-60.6 0.04
Poverty Threshold
<200% 218 51.4 43.1-59.7 ref 0.00 217 39.9 31.9-48.0 ref 0.00
200-299% 105 58.1 47.4-68.8 0.30 103 42.6 33.2-51.9 0.68
300-399% 61 85.8 77.5-94.0 0.00 61 72.6 60.3-84.9 0.00
400-599% 46 70.2 60.5-79.9 0.00 46 59.8 47.6-72.0 0.01
500%+ 105 77.9 68.3-87.5 0.00 102 60.6 50.9-70.4 0.00
Unknown 146 58.0 49.6-66.5 0.28 145 37.7 29.6-45.9 0.73
Region
Northeast 106 70.7 63.0-78.5 ref 0.20 103 54.2 45.8-62.6 ref 0.21
Midwest 116 56.4 48.0-64.9 0.02 116 41.5 32.4-50.5 0.04
South 397 62.2 56.5-67.9 0.08 395 46.3 41.3-51.4 0.12
West 62 61.7 49.4-74.0 0.22 60 48.3 35.2-61.3 0.45
Metropolitan Statistical Area
No 103 48.7 40.6-56.7 ref 0.00 102 37.9 31.3-44.6 ref 0.01
Yes 578 65.6 60.8-70.3 0.00 572 49.3 44.8-53.8 0.01
Family Composition
Marital Status
Married/living with partner 317 70.1 63.8-76.5 ref 0.01 314 54.2 47.9-60.5 ref 0.03
Widowed 73 62.0 48.1-75.9 0.28 73 53.4 35.6-71.1 0.93
Divorced or Separated 181 56.9 49.1-64.7 0.01 181 40.0 32.9-47.2 0.01
Never married 109 47.4 37.0-57.8 0.00 105 30.6 21.5-39.8 0.00
Family Size (Persons in Family)
1 318 53.2 47.7-58.7 ref 0.00 314 37.8 32.8-42.7 ref 0.00
2 217 68.5 61.8-75.2 0.00 215 52.3 45.8-58.8 0.00
3+ 146 69.6 62.2-76.9 0.00 145 54.2 46.3-62.1 0.00
Family Structure
One adult, no children 318 53.2 47.7-58.7 ref 0.00 314 37.8 32.8-42.7 ref 0.00
Multiple adults, no children 251 67.1 60.3-73.9 0.00 248 52.8 46.3-59.3 0.00
One adult, 1+ children 14 92.0 83.4- 100 0.00 14 88.1 76.2-99.9 0.00
Multiple adults, 1+ children 98 65.5 54.9-76.0 0.05 98 44.3 35.7-52.9 0.23
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also more likely to have had the PSA test. In adjusted
analyses, men aged 50–64 years had twice the odds,
and men ≥65 had more than three times the odds of hav-
ing heard of the PSA test as men aged 45–59 (Table 3,
column 1). The odds of having heard of the PSA test
increased with each level of education over the refer-
ence group. Finally, men with private or military health
insurance had more than twice the odds of having heard
of the PSA test than men without health insurance.
For ever having had the PSA test (Table 3 column 2),
only one sociodemographic and three health status vari-
ables remained significant in the adjusted model. As
expected, men 50–64 had over twice the odds and men
aged ≥65 over four times the odds of ever having the
PSA test as the referent (men aged 45–49). Men with
private or military health insurance, those in fair or poor
health, and those with a family history of prostate cancer
were more likely than their referents to have had the test.
Discussion
The present study, which relied on the 2000
NHIS, indicates that in that year almost two-thirds
of African-American men aged ≥45 who did not
have prostate cancer had heard of the test and almost
half had had the test.
The literature varies on the percentage of men
who have had the PSA test, reflecting in part no
doubt the different focuses of the surveys. In four
studies, rates were 30–60%,14,25-27 but a more recent
study, which used 2001 data from the Behavioral
Risk Factor Surveillance system for men aged ≥50
in all 50 states, found a rate of 75%.28
The present study was similar to other published
studies in finding that certain demographic variables
were associated with both having heard of the PSA test
and ever having had a PSA test.6,13-16,20,29 In the multivari-
ate model, however, relationships with demographic
variables identified in previous studies (i.e., level of edu-
cation, income, region, MSA status and at least one oth-
er variable, marital status) were not found to have signif-
icant associations with the two outcome variables.
In the present study, single, never-married
African-American men had the lowest percentages
for both having heard of the PSA test and ever being
tested. This group warrants further investigation.
Perhaps being married and residing in a household
Table 2 continued
Heard of PSA Test Ever Had a PSA Test
N %a CIb GLC Wald N %a CIb GLC Wald
PVc PVd PVc PVd
Health Status
Health Insurance
None 94 39.6 27.9-51.2 0.00 0.00 93 21.8 11.1-32.5 0.00 0.00
Public 171 49.0 38.9-59.2 0.00 169 39.5 30.1-48.8 0.00
Private/military 411 74.7 69.9-79.5 ref 407 58.2 52.9-63.6 ref
Health Status
Excellent 110 65.5 53.6-77.3 ref 0.72 109 46.5 35.6-57.4 ref 0.42
Very good 156 60.2 52.6-67.8 0.47 152 40.2 32.4-48.0 0.33
Good 225 66.1 59.0-73.3 0.93 224 51.0 44.0-58.0 0.49
Fair or poor 186 57.7 49.4-66.0 0.26 185 48.2 40.8-55.6 0.79
Family History of Prostate Cancer
Yes 42 76.0 64.3-87.7 0.03 0.04 42 64.2 52.0-76.4 0.01 0.02
No 625 62.0 57.4-66.7 ref 617 46.1 41.9-50.4 ref
Had Colorectal Screeningf
Yes 138 85.4 78.9-91.9 0.00 0.00 137 81.9 74.8-89.1 0.00 0.00
No 362 58.0 52.3-63.7 ref 357 39.6 34.3-45.0 ref
Perceived Risk
Perceived Risk of Getting cancer
Low 399 63.9 58.2-69.5 ref 0.52 395 48.4 42.5-54.3 ref 0.81
Medium 140 64.2 56.4-72.1 0.93 139 48.6 39.7-57.5 0.98
High 48 63.2 49.7-76.8 0.93 46 51.0 37.3-64.7 0.74
Perceived Amount of Cancer in Family
Low 507 62.3 57.1-67.6 ref 0.14 501 47.5 42.1-52.9 ref 0.38
Medium 107 69.6 60.5-78.7 0.17 106 52.9 42.6-63.1 0.41
High 31 82.7 70.7-94.7 0.00 30 68.2 50.5-85.9 0.04
a Standardized to the 2000 Standard Million by five-year age groups except for age; b 95% Confidence Limits; c P values for a general
linear contrast comparing a row percent to its reference level. The reference levels are labeled ref; d P values for a Wald Chi-squared
test for the main effect of the bivariate logistic model outcome= main-effect + age; e Excluding men with prostate cancer; f Excluding
men 44 years of age or younger
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with multiple adults offers more support for discus-
sions about prostate cancer and the PSA test.15 Alter-
natively perhaps, men who have never been married
are less concerned about prostate cancer and its
implications than are men who have been married. 
In another study, men with a family history of
prostate cancer perceived themselves at increased
risk and were more likely than those without a histo-
ry to self-refer to a physician for PSA testing, while
men without a history were more likely to have
screening recommended to them by a health profes-
sional, friend or family member.30 In a study by
Demark-Wahnefried et al., many men did not know
that race and heredity were risk factors,6 and
McDavid and coworkers found that many men did
not have an opinion about their risk of getting
prostate cancer.31 Finally, in another study, having a
family history of prostate cancer was also associated
with use of the PSA test.9
In the current study, which is based entirely on
self-reports, an estimated 94% of African-American
men without prostate cancer had no history of the dis-
Table 3. Adjusted Odds Ratios of Non-Hispanic Black Mena Age 45 or Older
Who Have Heard of a PSA Test or Having Been Tested, by Population Subgroups
Have You Heard of a PSA Test? Have You Ever Had a PSA Test? 
(n=560) (n=553)
Odds Ratio CIb Wald PVc Odds Ratio CIb Wald PVc
Sociodemographics
Age (Years)
45 to 49 ref 0.00 ref 0.00
50 to 64 2.04 1.13-3.69 2.52 1.48-4.28
65+ 3.31 1.88-5.83 4.44 2.29-8.61
Education
< High school graduate ref 0.03 ref 0.11
High school graduate 1.88 1.04-3.41 1.28 0.72-2.30
Some college/tech school 2.33 1.17-4.67 2.25 1.16-4.40
College grad 3.07 1.23-7.64 1.39 0.68-2.87
Poverty Threshold
<200% ref 0.17 ref 0.12
200-299% 0.61 0.31-1.21 0.54 0.24-1.19
300-399% 2.37 1.01-5.60 1.97 0.82-4.73
400-599% 1.03 0.36-2.99 1.37 0.51-3.66
500%+ 1.25 0.54-2.91 1.05 0.46-2.39
Unknown 1.03 0.56-1.91 0.82 0.45-1.50
Region
Northeast ref 0.49 ref 0.53
Midwest 0.70 0.27-1.82 0.61 0.29-1.30
South 0.87 0.37-2.05 0.73 0.38-1.42
West 0.47 0.15-1.50 0.53 0.18-1.52
Metropolitan Statistical Area
No ref 0.05 ref 0.24
Yes 1.76 1.00-3.09 1.47 0.78-2.78
Family Composition
Marital Status
Married/living with partner ref 0.64 ref 0.28
Widowed 0.77 0.31-1.90 1.37 0.53-3.55
Divorced or Separated 1.25 0.52-3.02 1.55 0.65-3.69
Never married 1.05 0.38-2.89 0.80 0.21-3.12
Family Size (Persons in Family)
1 ref 0.47 ref 0.42
2 1.62 0.73-3.62 1.69 0.77-3.72
3+ 1.37 0.54-3.51 1.76 0.64-4.86
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ease in their family. In a smaller study of men who
participated in a free program for detecting prostate
cancer, 40% of the men reported a family history.30
Perhaps the figure in the present study is an underesti-
mate that resulted from less awareness among our
sample of prostate cancer in their families.6
Variables for perceived risk have been examined
in the literature, especially in behavioral stud-
ies.8,13,30,32 We found no relationship between per-
ceived risk of getting cancer in general and either
having heard of the PSA test or ever being tested.
One study linked a family history of prostate cancer
with greater perceived risk, but perceived risk was
not directly related to test use.30 Perhaps if the ques-
tions about risk in the 2000 NHIS had been more
specific to prostate cancer, associations would have
been observed. In examining the family history vari-
able and the two variables for perceived risk, one
might consider that many African-American men,
despite having both higher incidence and mortality
from prostate cancer as a group, might be less aware
of the disease and be misinformed about the risk of
prostate cancer or have little knowledge of their per-
sonal risk.13,31
We found that 63% of African-American men
aged ≥45 who did not have prostate cancer had
heard of the PSA test, a figure that was lower than
previous studies have found for African-American
men. We also found that men not living in an MSA,
a group that would include many rural residents,
were not as aware of the PSA test and were less like-
ly to have been tested than urban residents (who
lived within an MSA), but we could not find any
results for MSA status in the literature.33
This study has several strengths. Few studies have
focused specifically on African-American men and
on topics related to the PSA test, especially at the
national level. Data for the current study were taken
from a large, nationally representative survey which
oversampled African-American men. The present
study specifically targeted African-American men
and examined within-group variations. Accordingly,
our findings might be useful for those developing rec-
ommendations for policy or decision tools. 
This study also has some limitations. One of the
outcome variables—having ever had a PSA test—
did not distinguish between one-time and more fre-
quent use. No doubt some men had had only one
PSA test with no follow-up, while others had several
tests. It is important to ask men about screening his-
Table 3 continued
Have You Heard of a PSA Test? Have You Ever Had a PSA Test?
(n=560) (n=553)
Odds Ratio CIb Wald PVc Odds Ratio CIb Wald PVc
Health Status
Health Insurance
None ref 0.00 ref 0.00
Public 0.76 0.34-1.68 1.40 0.57-3.48
Private/military 2.37 1.23-4.55 3.60 1.63-7.96
Health Status
Excellent ref 0.28 ref 0.04
Very good 0.94 0.43-2.09 0.94 0.46-1.91
Good 1.64 0.75-3.55 1.63 0.86-3.11
Fair or poor 1.74 0.77-3.93 2.44 1.13-5.28
Family History of Prostate Cancer
Yes 1.53 0.53-4.38 0.43 2.33 1.03-5.28 0.04
No ref ref
Perceived Risk
Perceived Risk of Getting Cancer
Low ref 0.78 ref 0.61
Medium 0.81 0.44-1.50 0.72 0.37-1.39
High 1.04 0.38-2.82 0.88 0.32-2.39
Perceived Amount of Cancer in Family
Low ref 0.24 ref 0.43
Medium 1.55 0.80-3.01 1.21 0.57-2.58
High 2.71 0.67-0.98 2.23 0.66-7.55
a Excluding men with prostate cancer; b 95% confidence limits; c P-value for a Wald chi-square main effect test.
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tory and frequency to have indicators of compliance
for organizations that recommend screening as well
as to gauge the extent that men use informed deci-
sion-making. Furthermore, respondents to the NHIS
may not have known whether they had had the test
since physicians may offer a battery of tests during
routine or other office visits, and it is possible that
patients were not aware of the purpose of some of
those tests (one of which might have measured PSA
levels). There is also the possible limitation of self-
report when conducting one-on-one interviews.
Misreporting can occur and can vary among individ-
uals and groups, which could lead to bias.34,35
Findings from this present study offer some
insight for possible research. Future studies and
interventions aimed at defined groups of men (e.g.,
men who reside in rural areas, African-American
men) may be useful for gauging awareness of
prostate cancer screening and knowledge about the
disease. Based on the present study, several other
variables might be further explored. For example,
single, never-married men might be examined to
confirm their substantially lower awareness of the
PSA test and their lower use of that test. Roles of
persons, such as wives, partners, and “significant
others,” regarding awareness and test use might ben-
efit from further examination. Finally, variables
dealing with perceived risk should be explored in
greater detail, with risk of prostate cancer specified. 
This study also raises several issues regarding the
study of African-American men and prostate cancer:
1) How aware is this group of the controversies
about screening for prostate cancer (e.g., it has
not been proven that screening and treatment
actually improves survival)?
2) Where do African-American men get their infor-
mation about prostate cancer and the PSA test?
3) How knowledgeable is this group about their
family histories?
4) How much do African-American men know
about the incidence of prostate cancer, how it is
diagnosed, the nature of available treatments
(both their effectiveness and side effects) and the
role of age in making decisions about treatment?
5) Are there cultural explanations for the attitudes and
behaviors of African-American men related to
prostate cancer and PSA testing? As noted, African-
American men are at greater risk for being diag-
nosed with prostate cancer and at higher risk of
mortality from the disease. Some organizations rec-
ommend offering PSA testing at an earlier age for
African-American men and men with a family his-
tory of prostate cancer since they are at greater
risk,36 while others do not recommend PSA testing.37
However, all of the major medical organizations
recommend that doctors discuss with their patients
the benefits and risks of prostate cancer screening.38
In order for men to participate in informed or shared
decision-making, knowledge of prostate cancer
screening-related issues is crucial. 
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